N-terminal pro-B-type natriuretic peptide and echocardiographic abnormalities in severely obese patients: Correlation with visceral fat [11]

Clinical Chemistry

Volumn 52, Issue 6, 2006, Pages 1211-1213

  Malavazos, Alexis E ^a   Morricone, Lelio ^a   Marocchi, Alessandro ^a   Ermetici, Federica ^a   Ambrosi, Bruno ^a   Corsi, Massimiliano M ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ECG ABNORMALITY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE MASS; HEART PERFORMANCE; HUMAN; IMAGE ANALYSIS; LETTER; M MODE ECHOCARDIOGRAPHY; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADIPOSE TISSUE; ADULT; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HEART DISEASES; HUMANS; NATRIURETIC PEPTIDE, BRAIN; OBESITY; PEPTIDE FRAGMENTS; VISCERA;

EID: 33646945295     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.067736     Document Type: Letter

References (12)

1. Morricone L, Malavazos AE, Coman C, Donati C, Hassan T, Caviezel F. Echocardiographic abnormalities in normotensive obese patients: relationship with visceral fat. Obes Res 2002; 10:489-97.
2. Yamamoto K, Burnett JC, Jougasaki M, Nishimura R, Bailey K, Saito Y, et al. Superiority of brain natriuretic peptide as marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28: 988-94.
3. de Lemos JA, McGuire DC, Dranzer MH. B-Type natriuretic peptide in cardiovascular disease. Lancet 2003;262:316-22.
4. Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA. Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 2004;6:289-93.
5. Rivera M, Cortés R, Salvador A, Bertomeu V, de Burgos FG, Payà R, et al. Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of etiology. Eur J Heart Fail 2005;7: 1168-70.
6. Hermann-Arnhof KM, Hanusch-Enserer U, Kaestenbauer T, Publig T, Dunky A, Rosen HR, et al. N-Terminal pro-B-type natriuretic peptide as an indicator of possible cardiovascular disease in severely obese individuals: comparison with patients in different stages of heart failure. Clin Chem 2005;51:138-43.
7. Mueuer T, Gegenhuber A, Dieplinger B, Poelz W, Haltmayer M. Capacity of B-type natriuretic peptide (BNP) and amino-terminal proBNP as indicators of cardiac structural disease in asymptomatic patients with systemic arterial hypertension. Clin Chem 2005; 51:2245-51.
8. Halse KG, Lindegaard MLS, Goetze JP, Damm P, Mathiesen ER, Nielsen LB. Increased pro-B-type natriuretic peptide in infants of women with type I diabetes. Clin Chem 2005;51: 2296-302.
9. Dessi-Fulgheri P, Sarzani R, Rapelli A. Role of the natriuretic peptide in lipogenesis/lipolysis. Nutr Metab Cardiovasc Dis 2003;13:244-9.
10. Williams MJ, Hunter GR, Kekes-Szabo T, Nicholson C, Berland L. Intra-abdominal adipose tissue cut-points related to elevated cardiovascular risk in women. Int J obes Relat Metab Disord 1996;20:613-7.
11. Sengenès C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB 2000;14:1345-51.
12. Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail 2004;6:261-8.